Evanston, IL, United States of America

Donye Dominguez

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Northwestern University. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Donye Dominguez: Innovator in Adoptive Cell Therapy

Introduction

Donye Dominguez is a prominent inventor based in Evanston, IL (US). He has made significant contributions to the field of biotechnology, particularly in the area of adoptive cell therapy. His innovative work focuses on the use of spherical nucleic acids (SNAs) in therapeutic applications.

Latest Patents

Donye Dominguez holds 1 patent related to his groundbreaking research. His patent, titled "Adoptive cell therapy using spherical nucleic acids (SNAs)," involves compositions that include a cell and a spherical nucleic acid comprising a nanoparticle, an oligonucleotide on the surface of the nanoparticle, and an antigen. The patent also outlines methods for producing these compositions and their applications, which include but are not limited to adoptive cell therapy.

Career Highlights

Donye Dominguez is affiliated with Northwestern University, where he continues to advance his research in the field of cell therapy. His work has the potential to revolutionize treatment options for various diseases by harnessing the power of the immune system.

Collaborations

Throughout his career, Donye has collaborated with notable scientists, including Chad A. Mirkin and Andrew Lee. These collaborations have further enriched his research and contributed to the advancement of innovative therapies.

Conclusion

Donye Dominguez is a key figure in the development of adoptive cell therapy, with a focus on spherical nucleic acids. His contributions to biotechnology are paving the way for new therapeutic approaches that could significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…